WHO warns 20,000 at risk from Ebola

GSK-led consortium plans to speed up experimental vaccine trials

The aid needed to stop Ebola’s spread

Foreign help is crucial in some of Africa’s poorest states

Chi-Med draws on the past for the future

Revenues from traditional medicines are helping to fund cutting-edge drugs

Hutchison China Meditech

Chinese pharma R&D marks step forward

Patients enrolled for study into homegrown cancer treatment

Roche: bets on discovery

Just because you can do something does not mean you should

Pfizer weighs options on AstraZeneca bid

Three months after deal collapsed, rules allow possible renewal

London doctors prepare for Ebola patient

Royal Free Hospital to treat Briton as epidemic worsens in west Africa

Roche to buy InterMune for $8.3bn

Latest example of feverish pharma deal activity

Drug cost watchdog chief urges honesty

NHS never able to afford every drug, says Dillon

Drugmaker link-up puts Astra on top

FTSE 100 gains pared by miners, which fell on China data

AstraZeneca probe closed without charges

US DoJ decision will boost sales of blood thinner Brilinta

Chugai shares soar on Roche buyout talk

Swiss group already owns 61.5% of Japanese drugmaker

Roche / Chugai: uptown problems

An expensive but low risk investment, if it happens

Roche to bid $10bn for control of Chugai

Japanese drugmaker denies any talks with Swiss group

IRS to probe Valeant tax returns

Agency examines tax affairs of Allergan bidder

Salmonella cases linked to single source

Investigators look for food ingredients used at different sites

Investigators accept China jail sentence

Briton and US wife became embroiled in GSK sex tape scandal

Takeover talk sparks InterMune move

US biotech group appoints advisers to assess options

Ebola is not an invincible superbug

New medicines will speed up victory over the virus

WHO backs experimental Ebola drugs


More FT Twitter accounts